Cresanto Global (BSE 531207)₹5.370.00%Pharmaceuticals
In the Mar 2026 quarter (standalone), Cresanto Global reported sales of ₹0 Cr and net profit of −₹0.23 Cr, down 483.3% year on year. For the year to Mar 2026, sales were ₹0.04 Cr and net profit −₹0.42 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
| Expenses | 0.02 | 0.03 | 0.03 | 0.06 | 0.03 | 0.03 | 0.27 | 0.35 | 0.10 | 0.07 | 0.12 | 0.09 |
| Operating Profit | 0.00 | −0.01 | −0.01 | −0.04 | −0.01 | −0.01 | −0.25 | −0.33 | −0.08 | 0.00 | −0.10 | −0.07 |
| OPM % | — | — | — | — | — | — | — | — | — | −20.0% | — | — |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.51 | 0.00 | 0.00 | 0.03 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 | 0.17 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.02 | −0.01 | −0.01 | −0.04 | −0.03 | −0.01 | −0.24 | 0.06 | −0.10 | 0.00 | −0.08 | −0.23 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | −0.01 | −0.01 | −0.01 | −0.04 | −0.01 | −0.01 | −0.24 | 0.06 | −0.08 | 0.00 | −0.08 | −0.23 |
| EPS (Rs) | −0.06 | −0.06 | −0.06 | −0.13 | −0.06 | −0.06 | −0.60 | 0.17 | −0.22 | −0.03 | −0.22 | −0.57 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 |
| Expenses | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 | 0.08 | 0.09 | 0.20 | 0.11 | 0.61 | 0.35 | 0.38 |
| Operating Profit | −0.02 | −0.02 | −0.02 | −0.02 | −0.05 | −0.06 | −0.07 | −0.18 | −0.09 | −0.59 | −0.28 | −0.25 |
| OPM % | — | — | — | — | — | — | — | — | — | — | −580.0% | −625.0% |
| Other Income | 0.00 | 0.00 | −0.03 | −0.01 | 0.02 | 0.02 | 0.00 | 0.01 | 0.00 | 0.52 | 0.01 | 0.03 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.17 | 0.17 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.03 | −0.04 | −0.05 | −0.07 | −0.05 | −0.08 | −0.08 | −0.19 | −0.09 | −0.17 | −0.42 | −0.41 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Exceptional items | −0.03 | −0.03 | −0.04 | −0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.52 | 0.00 | — |
| Net Profit | −0.03 | −0.04 | −0.05 | −0.04 | −0.05 | −0.06 | −0.07 | −0.16 | −0.09 | −0.17 | −0.42 | −0.39 |
| EPS (Rs) | −0.10 | −0.13 | −0.15 | −0.13 | −0.15 | −0.17 | −0.20 | −0.41 | −0.24 | −0.43 | −1.02 | −1.04 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.26 | 4.26 | 4.26 | 4.27 | 4.26 | 4.27 | 4.27 | 4.26 | 4.26 | 4.27 | 4.26 | 4.26 |
| Reserves | −6.00 | −6.04 | −6.09 | −6.16 | −6.20 | −6.27 | −6.34 | −6.42 | −6.59 | −6.68 | −6.87 | −7.30 |
| Borrowings | 2.01 | 2.00 | 2.04 | 2.05 | 2.06 | 2.08 | 2.22 | 0.06 | 0.00 | 2.44 | 2.38 | 2.82 |
| Other Liabilities | 0.04 | 0.06 | 0.07 | 0.11 | 0.14 | 0.18 | 0.10 | 2.34 | 2.49 | 0.13 | 0.25 | 0.22 |
| Total Liabilities | 0.31 | 0.28 | 0.28 | 0.27 | 0.26 | 0.26 | 0.25 | 0.24 | 0.16 | 0.16 | 0.02 | 0.00 |
| Fixed Assets | 0.21 | 0.20 | 0.20 | 0.19 | 0.18 | 0.18 | 0.17 | 0.17 | 0.16 | 0.16 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.10 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.00 | 0.00 | 0.02 | 0.00 |
| Trade receivables | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & equivalents | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 0.31 | 0.28 | 0.28 | 0.27 | 0.26 | 0.26 | 0.25 | 0.24 | 0.16 | 0.16 | 0.02 | 0.00 |
| Mar 2015 | Mar 2016 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.04 | 0.00 | −2.20 | −0.15 | −0.05 | −0.46 | −0.42 |
| Cash from investing activity | 0.00 | 0.00 | 2.22 | 0.17 | 0.07 | 0.60 | 0.45 |
| Cash from financing activity | 0.04 | −0.02 | 0.00 | 0.00 | 0.00 | −0.12 | 0.00 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Free cash flow | −0.04 | 0.02 | −2.22 | −0.17 | −0.07 | 0.19 | −0.44 |
| CFO / OP % | 75.0% | −33.0% | 2,762.0% | 84.0% | 60.0% | 78.0% | 148.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | — | — | — | — | — | — | — | 0 |
| Inventory days | — | — | — | — | — | — | — | 0 |
| Cash conversion cycle | — | — | — | — | — | — | — | 0 |
| Working capital days | — | — | — | — | — | — | — | −1,606 |
| ROCE % | −7.9% | −8.2% | −14.0% | −16.3% | −21.5% | −60.1% | −60.9% | — |
For the Mar 2026 quarter, Cresanto Global reported sales of ₹0 Cr and net profit of −₹0.23 Cr, down 483.3% year on year.
Cresanto Global's sales for the year to Mar 2026 were ₹0.04 Cr; over the last twelve months they were ₹0.04 Cr.
Net profit for the year to Mar 2026 was −₹0.42 Cr, and −₹0.39 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−1.04.
Cresanto Global reported borrowings of ₹2.82 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.
Cash from operations was −₹0.42 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.44 Cr.